A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)

NCT06072430 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Septic Shock
Sepsis
Hypovolemia

Interventions

DRUG: VBI-S

Sponsor

Vivacelle Bio